Courier Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$284K Sell
3,302
-30
-0.9% -$2.63K 0.01% 347
2026
Q1
$301K Hold
3,332
0.02% 328
2025
Q4
$300K Sell
3,332
-2,275
-41% -$216K 0.02% 324
2025
Q3
$552K Buy
5,607
+17
+0.3% +$1.69K 0.03% 270
2025
Q2
$510K Sell
5,590
-80
-1% -$7.74K 0.03% 272
2025
Q1
$642K Hold
5,670
0.04% 242
2024
Q4
$599K Sell
5,670
-384
-6% -$41.2K 0.04% 236
2024
Q3
$654K Buy
6,054
+1,910
+46% +$208K 0.04% 222
2024
Q2
$450K Sell
4,144
-160
-4% -$18.9K 0.04% 236
2024
Q1
$568K Sell
4,304
-150
-3% -$18.7K 0.04% 230
2023
Q4
$542K Hold
4,454
0.04% 230
2023
Q3
$500K Hold
4,454
0.04% 235
2023
Q2
$649K Sell
4,454
-1,000
-18% -$136K 0.05% 214
2023
Q1
$705K Sell
5,454
-80
-1% -$10K 0.08% 142
2022
Q4
$706K Hold
5,534
0.08% 139
2022
Q3
$579K Buy
5,534
+25
+0.5% +$2.74K 0.07% 153
2022
Q2
$579K Buy
5,509
+199
+4% +$23.6K 0.07% 156
2022
Q1
$679K Buy
5,310
+13
+0.2% +$1.57K 0.07% 155
2021
Q4
$653K Sell
5,297
-1,680
-24% -$220K 0.06% 165
2021
Q3
$991K Sell
6,977
-70
-1% -$10.3K 0.09% 134
2021
Q2
$1.1M Hold
7,047
0.1% 132
2021
Q1
$1.09M Buy
7,047
+1,803
+34% +$279K 0.11% 126
2020
Q4
$784K Hold
5,244
0.09% 137
2020
Q3
$705K Buy
5,244
+166
+3% +$21.7K 0.08% 140
2020
Q2
$595K Hold
5,078
0.08% 145
2020
Q1
$553K Hold
5,078
0.08% 136
2019
Q4
$733K Sell
5,078
-41
-0.8% -$5.66K 0.09% 131
2019
Q3
$661K Sell
5,119
-31
-0.6% -$4K 0.09% 135
2019
Q2
$589K Sell
5,150
-143
-3% -$16.7K 0.08% 153
2019
Q1
$656K Hold
5,293
0.09% 141
2018
Q4
$533K Sell
5,293
-67
-1% -$7.54K 0.08% 150
2018
Q3
$684K Sell
5,360
-98
-2% -$11.7K 0.08% 149
2018
Q2
$591K Hold
5,458
0.08% 160
2018
Q1
$578K Sell
5,458
-5
-0.1% -$581 0.08% 152
2017
Q4
$640K Sell
5,463
-38
-0.7% -$4.3K 0.08% 143
2017
Q3
$625K Hold
5,501
0.09% 134
2017
Q2
$686K Hold
5,501
0.12% 125
2017
Q1
$652K Hold
5,501
0.11% 128
2016
Q4
$551K Hold
5,501
0.11% 132
2016
Q3
$694K Sell
5,501
-1,030
-16% -$127K 0.14% 117
2016
Q2
$763K Sell
6,531
-1,239
-16% -$140K 0.15% 115
2016
Q1
$576K Buy
7,770
+2,162
+39% +$209K 0.12% 128
2015
Q4
$559K Sell
5,608
-114
-2% -$11.2K 0.12% 129
2015
Q3
$522K Hold
5,722
0.12% 136
2015
Q2
$607K Sell
5,722
-211
-4% -$23.3K 0.12% 134
2015
Q1
$677K Sell
5,933
-41
-0.7% -$4.68K 0.13% 126
2014
Q4
$658K Sell
5,974
-82
-1% -$8.64K 0.13% 131
2014
Q3
$591K Hold
6,056
0.12% 140
2014
Q2
$611K Buy
6,056
+82
+1% +$8K 0.12% 146
2014
Q1
$549K Hold
5,974
0.11% 154
2013
Q4
$541K Hold
5,974
0.12% 152
2013
Q3
$476K Sell
5,974
-5
-0.1% -$394 0.11% 151
2013
Q2
$435K Buy
+5,979
New +$447K 0.11% 152

Other funds holding ZBH

Courier Capital's ZBH Position: Q2 2026 in Review

Courier Capital reduced its Zimmer Biomet (ZBH) stake by 0.9% in Q2 2026, selling an estimated $2.63K and leaving 3,302 shares worth $284K. The position accounts for 0.01% of the portfolio, ranked #347.

Courier Capital first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.1M in Q2 2021. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Courier Capital held 3,302 shares of Zimmer Biomet worth $284K as of Q2 2026.
  • Courier Capital sold 30 Zimmer Biomet shares in Q2 2026, an estimated $2.63K.
  • Zimmer Biomet made up 0.01% of Courier Capital's portfolio in Q2 2026, its #347 holding.
  • Courier Capital first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Courier Capital's Zimmer Biomet position peaked at $1.1M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.